NCT06868888

Brief Summary

End-stage renal disease (ESRD) disrupts erythrocyte deformability due to osmotic imbalances, oxidative stress, and uremic toxins, leading to impaired microcirculation and oxygen transport. Dysregulation of ion channels, particularly the Gardos channel, exacerbates dehydration and eryptosis, further compromising vascular integrity. Given the critical role of erythrocyte flexibility in oxygen delivery, this study investigates its relationship with aerobic capacity in ESRD patients, highlighting potential mechanisms of microvascular dysfunction

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2022

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

March 5, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2025

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

2.6 years

First QC Date

March 5, 2025

Last Update Submit

March 5, 2025

Conditions

Keywords

HemodialysisAerobic capacityDeformabilityErythrocyte

Outcome Measures

Primary Outcomes (3)

  • Deformability of erythrocytes

    Deformability refers to the cells' ability to adapt their shape to the dynamically changing flow conditions so as to minimize their resistance to flow.

    Data collection was completed within one week of participant enrollment

  • Aggregation of erythrocytes

    Erythrocyte aggregation is the reversible clumping of red blood cells (RBCs) under low shear forces or at stasis.

    Data collection was completed within one week of participant enrollment

  • Cardiopulmonary fitness

    ESRD patients performed cardiopulmonary exercise testing (CPET) to assess their aerobic capacity. CPET composed of continuous workload increment of 10 W/min until exhaustion (usually within 8-12 minutes). Oxygen consumption, carbon dioxide production, ventilation, respiratory rate would be recorded.

    Data collection was completed within one week of participant enrollment

Secondary Outcomes (2)

  • Quality of life in ESRD patients

    Data collection was completed within one week of participant enrollment

  • Gardos function

    Data collection was completed within one week of participant enrollment

Study Arms (2)

ESRD

ESRD patients under hemodialysis

Other: Blood collectionOther: Cardiopulmonary exercise testing (CPET)

Health control

Healthy sedentary volunteers

Other: Blood collectionOther: Cardiopulmonary exercise testing (CPET)

Interventions

Erythrocyte osmotic deformability was evaluated via osmotic gradient ektacytometry.

ESRDHealth control

Cardiopulmonary Exercise Testing (CPET) is a non-invasive assessment that evaluates the integrated function of the cardiovascular, pulmonary, and muscular systems during exercise.

ESRDHealth control

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study included 18 patients with end-stage renal disease (ESRD) and 18 age-matched healthy controls. ESRD patients were recruited and with inclusion criteria requiring a confirmed diagnosis of ESRD and stable dialysis treatment for at least three months. Healthy controls were free of chronic illnesses and were matched by age and sex. Exclusion criteria included a history of hyperkalemia within the past three months, heart failure, pregnancy, or any condition contraindicating cardiopulmonary exercise testing. All participants underwent assessments within one week of enrollment, and written informed consent was obtained before participation."

You may qualify if:

  • Receiving hemodialysis and medication at least for 6 weeks
  • Kt/V score \> 1.2

You may not qualify if:

  • Under 20 years-old
  • Hyperkalemia occurs within 3 month
  • Having orthopedic or muscular diseases
  • Other concerned medical, psychological or physiological diseases
  • Pregnancy
  • Other exercise contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung University

Taoyuan District, 333, Taiwan

RECRUITING

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Blood Specimen CollectionExercise Test

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesHeart Function TestsDiagnostic Techniques, CardiovascularRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometry

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 5, 2025

First Posted

March 11, 2025

Study Start

August 24, 2022

Primary Completion

March 20, 2025

Study Completion

March 26, 2025

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations